- Home
- ABSI vs TCPC Comparison
ABSI vs TCPC Comparison
Compare ABSI & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- TCPC
- Stock Information
- Founded
- ABSI 2011
- TCPC 2006
- Country
- ABSI United States
- TCPC United States
- Employees
- ABSI N/A
- TCPC N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- TCPC Finance/Investors Services
- Sector
- ABSI Health Care
- TCPC Finance
- Exchange
- ABSI Nasdaq
- TCPC Nasdaq
- Market Cap
- ABSI 505.4M
- TCPC 603.8M
- IPO Year
- ABSI 2021
- TCPC 2012
- Fundamental
- Price
- ABSI $4.53
- TCPC $5.58
- Analyst Decision
- ABSI Strong Buy
- TCPC Sell
- Analyst Count
- ABSI 6
- TCPC 2
- Target Price
- ABSI $7.98
- TCPC $6.75
- AVG Volume (30 Days)
- ABSI 7.2M
- TCPC 846.4K
- Earning Date
- ABSI 11-11-2025
- TCPC 11-06-2025
- Dividend Yield
- ABSI N/A
- TCPC 21.75%
- EPS Growth
- ABSI N/A
- TCPC N/A
- EPS
- ABSI N/A
- TCPC N/A
- Revenue
- ABSI $4,138,000.00
- TCPC $239,535,768.00
- Revenue This Year
- ABSI $32.44
- TCPC N/A
- Revenue Next Year
- ABSI $359.77
- TCPC N/A
- P/E Ratio
- ABSI N/A
- TCPC N/A
- Revenue Growth
- ABSI 27.32
- TCPC 3.11
- 52 Week Low
- ABSI $2.01
- TCPC $5.39
- 52 Week High
- ABSI $6.33
- TCPC $9.72
- Technical
- Relative Strength Index (RSI)
- ABSI 64.46
- TCPC 29.09
- Support Level
- ABSI $3.45
- TCPC $5.39
- Resistance Level
- ABSI $5.23
- TCPC $5.87
- Average True Range (ATR)
- ABSI 0.42
- TCPC 0.16
- MACD
- ABSI 0.12
- TCPC 0.01
- Stochastic Oscillator
- ABSI 67.50
- TCPC 25.28
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About TCPC BlackRock TCP Capital Corp.
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.